Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands-Reference-Cited by-同舟云学术

Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands

Published:2012 Issue:5 Volume:3 Page:627
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Lecoutey Cédric,Rochais Christophe,Genest David,Butt-Gueulle Sabrina,Ballandonne Céline,Corvaisier Sophie,Dulin Fabienne,Lepailleur Alban,Sopkova-de Oliveira Santos Jana,Dallemagne Patrick

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2012/MD/C2MD20063E

Reference32 articles.

1. Therapies for Alzheimer's disease

2. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

3. Can the pharmaceutical industry reduce attrition rates?

4. Fragments, network biology and designing multiple ligands

5. From magic bullets to designed multiple ligands

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The chemistry of heterocycles in the 21st century;Russian Chemical Reviews;2024-07

2. Bicyclic 5-6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 0:1;Comprehensive Heterocyclic Chemistry IV;2022

3. Multitarget Directed Ligand Approaches for Alzheimer’s Disease: A Comprehensive Review;Mini-Reviews in Medicinal Chemistry;2021-11-23

4. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease;Current Medicinal Chemistry;2021-05-12

5. Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease;European Journal of Medicinal Chemistry;2021-01